AAPL281.85-1.93 (-0.68%) ▼|ABBV255.27+1.92 (+0.76%) ▲|ABT92.83-1.29 (-1.37%) ▼|ACN125.04-3.94 (-3.05%) ▼|ADBE205.97+3.24 (+1.60%) ▲|AMAT697.48+70.64 (+11.27%) ▲|AMD536.72+15.14 (+2.90%) ▲|AMGN359.93+1.60 (+0.45%) ▲|AMT167.94-7.66 (-4.36%) ▼|AMZN240.09+7.40 (+3.18%) ▲|AVGO373.33+8.31 (+2.28%) ▲|AXP341.46+1.10 (+0.32%) ▲|BA215.26-1.99 (-0.92%) ▼|BAC58.04+0.16 (+0.28%) ▲|BKNG183.39+1.93 (+1.06%) ▲|BLK952.72-11.99 (-1.24%) ▼|BMY58.45+0.93 (+1.62%) ▲|BNY144.11+0.55 (+0.38%) ▲|BRK-B495.95-2.71 (-0.54%) ▼|C142.79+1.03 (+0.73%) ▲|CAT1,033.24+35.77 (+3.59%) ▲|CL91.98-0.09 (-0.10%) ▼|CMCSA24.44+1.27 (+5.46%) ▲|COF202.35-1.65 (-0.81%) ▼|COP104.43-1.53 (-1.44%) ▼|COST944.98-7.56 (-0.79%) ▼|CRM158.45+0.08 (+0.05%) ▲|CSCO117.47+3.70 (+3.25%) ▲|CVS103.36-0.98 (-0.94%) ▼|CVX168.84-2.22 (-1.30%) ▼|DE624.07+10.83 (+1.77%) ▲|DHR193.19-3.00 (-1.53%) ▼|DIS98.65-0.14 (-0.14%) ▼|DUK128.03-0.37 (-0.29%) ▼|EMR142.90-0.59 (-0.41%) ▼|FDX324.51+5.98 (+1.88%) ▲|GD348.45+1.74 (+0.50%) ▲|GE373.26+4.26 (+1.15%) ▲|GEV1,099.27+54.10 (+5.18%) ▲|GILD126.10-1.78 (-1.39%) ▼|GM77.52-0.59 (-0.75%) ▼|GOOG350.91+16.22 (+4.84%) ▲|GOOGL353.32+15.93 (+4.72%) ▲|GS1,023.93+4.32 (+0.42%) ▲|HD349.92+1.06 (+0.30%) ▲|HON227.58-15.84 (-6.51%) ▼|IBM277.65+6.02 (+2.22%) ▲|INTC130.38+2.06 (+1.61%) ▲|INTU267.20-0.52 (-0.19%) ▼|ISRG405.76+1.49 (+0.37%) ▲|JNJ257.94+3.28 (+1.29%) ▲|JPM330.84+1.79 (+0.54%) ▲|KO82.58-0.05 (-0.06%) ▼|LIN510.87-8.75 (-1.68%) ▼|LLY1,228.14+20.02 (+1.66%) ▲|LMT503.10-4.30 (-0.85%) ▼|LOW220.15-2.34 (-1.05%) ▼|LRCX409.83+30.74 (+8.11%) ▲|MA510.87+11.85 (+2.37%) ▲|MCD267.18-2.58 (-0.96%) ▼|MDLZ60.11-0.69 (-1.13%) ▼|MDT80.74-0.25 (-0.30%) ▼|META564.45+14.20 (+2.58%) ▲|MMM162.43-1.59 (-0.97%) ▼|MO73.85+0.06 (+0.08%) ▲|MRK129.36+0.70 (+0.54%) ▲|MS212.57+0.54 (+0.25%) ▲|MSFT368.04-4.93 (-1.32%) ▼|MU1,128.19-4.14 (-0.37%) ▼|NEE88.53-0.03 (-0.03%) ▼|NFLX73.88+0.07 (+0.09%) ▲|NKE41.32+0.57 (+1.40%) ▲|NOW99.83+1.49 (+1.52%) ▲|NVDA194.62+2.09 (+1.09%) ▲|ORCL148.25-0.28 (-0.19%) ▼|PEP138.10-3.29 (-2.33%) ▼|PFE24.41+0.12 (+0.49%) ▲|PG147.91-1.11 (-0.74%) ▼|PLTR116.21+3.28 (+2.90%) ▲|PM182.48+1.71 (+0.95%) ▲|QCOM187.52-1.88 (-0.99%) ▼|RTX187.74-0.25 (-0.13%) ▼|SBUX104.11-0.49 (-0.47%) ▼|SCHW90.52-0.16 (-0.17%) ▼|SO96.72-0.44 (-0.45%) ▼|SPG227.69+0.80 (+0.35%) ▲|T21.79-0.93 (-4.09%) ▼|TMO505.11-7.92 (-1.54%) ▼|TMUS173.83-8.86 (-4.85%) ▼|TSLA411.51+31.80 (+8.37%) ▲|TXN284.54-0.89 (-0.31%) ▼|UBER75.20-1.00 (-1.31%) ▼|UNH418.44-9.45 (-2.21%) ▼|UNP272.41+4.06 (+1.51%) ▲|UPS107.98-0.16 (-0.15%) ▼|USB61.40+0.49 (+0.80%) ▲|V342.23+6.00 (+1.78%) ▲|VZ44.09-2.45 (-5.26%) ▼|WFC83.84-0.03 (-0.03%) ▼|WMT114.83-0.86 (-0.74%) ▼|XOM136.09-0.46 (-0.33%) ▼|AAPL281.85-1.93 (-0.68%) ▼|ABBV255.27+1.92 (+0.76%) ▲|ABT92.83-1.29 (-1.37%) ▼|ACN125.04-3.94 (-3.05%) ▼|ADBE205.97+3.24 (+1.60%) ▲|AMAT697.48+70.64 (+11.27%) ▲|AMD536.72+15.14 (+2.90%) ▲|AMGN359.93+1.60 (+0.45%) ▲|AMT167.94-7.66 (-4.36%) ▼|AMZN240.09+7.40 (+3.18%) ▲|AVGO373.33+8.31 (+2.28%) ▲|AXP341.46+1.10 (+0.32%) ▲|BA215.26-1.99 (-0.92%) ▼|BAC58.04+0.16 (+0.28%) ▲|BKNG183.39+1.93 (+1.06%) ▲|BLK952.72-11.99 (-1.24%) ▼|BMY58.45+0.93 (+1.62%) ▲|BNY144.11+0.55 (+0.38%) ▲|BRK-B495.95-2.71 (-0.54%) ▼|C142.79+1.03 (+0.73%) ▲|CAT1,033.24+35.77 (+3.59%) ▲|CL91.98-0.09 (-0.10%) ▼|CMCSA24.44+1.27 (+5.46%) ▲|COF202.35-1.65 (-0.81%) ▼|COP104.43-1.53 (-1.44%) ▼|COST944.98-7.56 (-0.79%) ▼|CRM158.45+0.08 (+0.05%) ▲|CSCO117.47+3.70 (+3.25%) ▲|CVS103.36-0.98 (-0.94%) ▼|CVX168.84-2.22 (-1.30%) ▼|DE624.07+10.83 (+1.77%) ▲|DHR193.19-3.00 (-1.53%) ▼|DIS98.65-0.14 (-0.14%) ▼|DUK128.03-0.37 (-0.29%) ▼|EMR142.90-0.59 (-0.41%) ▼|FDX324.51+5.98 (+1.88%) ▲|GD348.45+1.74 (+0.50%) ▲|GE373.26+4.26 (+1.15%) ▲|GEV1,099.27+54.10 (+5.18%) ▲|GILD126.10-1.78 (-1.39%) ▼|GM77.52-0.59 (-0.75%) ▼|GOOG350.91+16.22 (+4.84%) ▲|GOOGL353.32+15.93 (+4.72%) ▲|GS1,023.93+4.32 (+0.42%) ▲|HD349.92+1.06 (+0.30%) ▲|HON227.58-15.84 (-6.51%) ▼|IBM277.65+6.02 (+2.22%) ▲|INTC130.38+2.06 (+1.61%) ▲|INTU267.20-0.52 (-0.19%) ▼|ISRG405.76+1.49 (+0.37%) ▲|JNJ257.94+3.28 (+1.29%) ▲|JPM330.84+1.79 (+0.54%) ▲|KO82.58-0.05 (-0.06%) ▼|LIN510.87-8.75 (-1.68%) ▼|LLY1,228.14+20.02 (+1.66%) ▲|LMT503.10-4.30 (-0.85%) ▼|LOW220.15-2.34 (-1.05%) ▼|LRCX409.83+30.74 (+8.11%) ▲|MA510.87+11.85 (+2.37%) ▲|MCD267.18-2.58 (-0.96%) ▼|MDLZ60.11-0.69 (-1.13%) ▼|MDT80.74-0.25 (-0.30%) ▼|META564.45+14.20 (+2.58%) ▲|MMM162.43-1.59 (-0.97%) ▼|MO73.85+0.06 (+0.08%) ▲|MRK129.36+0.70 (+0.54%) ▲|MS212.57+0.54 (+0.25%) ▲|MSFT368.04-4.93 (-1.32%) ▼|MU1,128.19-4.14 (-0.37%) ▼|NEE88.53-0.03 (-0.03%) ▼|NFLX73.88+0.07 (+0.09%) ▲|NKE41.32+0.57 (+1.40%) ▲|NOW99.83+1.49 (+1.52%) ▲|NVDA194.62+2.09 (+1.09%) ▲|ORCL148.25-0.28 (-0.19%) ▼|PEP138.10-3.29 (-2.33%) ▼|PFE24.41+0.12 (+0.49%) ▲|PG147.91-1.11 (-0.74%) ▼|PLTR116.21+3.28 (+2.90%) ▲|PM182.48+1.71 (+0.95%) ▲|QCOM187.52-1.88 (-0.99%) ▼|RTX187.74-0.25 (-0.13%) ▼|SBUX104.11-0.49 (-0.47%) ▼|SCHW90.52-0.16 (-0.17%) ▼|SO96.72-0.44 (-0.45%) ▼|SPG227.69+0.80 (+0.35%) ▲|T21.79-0.93 (-4.09%) ▼|TMO505.11-7.92 (-1.54%) ▼|TMUS173.83-8.86 (-4.85%) ▼|TSLA411.51+31.80 (+8.37%) ▲|TXN284.54-0.89 (-0.31%) ▼|UBER75.20-1.00 (-1.31%) ▼|UNH418.44-9.45 (-2.21%) ▼|UNP272.41+4.06 (+1.51%) ▲|UPS107.98-0.16 (-0.15%) ▼|USB61.40+0.49 (+0.80%) ▲|V342.23+6.00 (+1.78%) ▲|VZ44.09-2.45 (-5.26%) ▼|WFC83.84-0.03 (-0.03%) ▼|WMT114.83-0.86 (-0.74%) ▼|XOM136.09-0.46 (-0.33%) ▼|
30.9 C
New York
Monday, June 29, 2026

Tag: patients

newssourceFORcompanyinformationcontent1releasesmarket

Fujitsu and Acer Medical trial AI service that assesses future disease risk in elderly patients through gait pattern abnormality detection

TOKYO, July 16, 2025 /PRNewswire/ -- Fujitsu Limited and Acer Medical Inc., a provider of AI-powered medical imaging and preventative medicine, today announced a...

Akeso Announces First Patient Enrolled in the Phase III Trial（AK112-312/HARMONi-GI6）of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer

HONG KONG, July 15, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the first patient has been successfully...

ArkBio’s Ziresovir Included into Pediatric RSV Drug Priority List by WHO

SHANGHAI, July 16, 2025 /PRNewswire/ -- In the newly released "Paediatric drug optimization for respiratory syncytial virus (PADO-RSV) meeting report" by Global Accelerator for...

ArkBio’s Ziresovir Included into Pediatric RSV Drug Priority List by WHO

SHANGHAI, July 16, 2025 /PRNewswire/ -- In the newly released "Paediatric drug optimization for respiratory syncytial virus (PADO-RSV) meeting report" by Global Accelerator for...

ArkBio’s Ziresovir Included into Pediatric RSV Drug Priority List by WHO

SHANGHAI, July 15, 2025 /PRNewswire/ -- In the newly released "Paediatric drug optimization for respiratory syncytial virus (PADO-RSV) meeting report" by Global Accelerator for...

Barrett Family Foundation Makes Historic Gift to Help Build Extraordinary in Healthcare

TORONTO, July 15, 2025 (GLOBE NEWSWIRE) -- In a defining moment for healthcare, the Barrett Family Foundation has made a transformative donation to St. Joseph’s Health Centre—part of Unity Health Toronto—to create the Barrett Centre for Quality Improvement (BCQI). This incredible act of generosity enables one of the most ambitious quality improvement programs ever undertaken at a Canadian hospital.

ELEVANCE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Elevance Health, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Elevance (ELV) To Contact Him Directly To Discuss Their Options

Menin Inhibitors Market Forecasts Signal Strong Uptake of Menin Inhibitors in Hematologic Oncology Across the 7MM During the Forecast Period (2020-2034) | DelveInsight

The menin inhibitor market is poised for rapid growth, with REVUFORJ setting the foundation and a strong pipeline of innovative, genetically targeted therapies on...

Menin Inhibitors Market Forecasts Signal Strong Uptake of Menin Inhibitors in Hematologic Oncology Across the 7MM During the Forecast Period (2020-2034) | DelveInsight

The menin inhibitor market is poised for rapid growth, with REVUFORJ setting the foundation and a strong pipeline of innovative, genetically targeted therapies on...

Biotricity to Host Fiscal 2025 Fourth Quarter Financial Results and Business Update Call on July 18th

Company to announce improvements in Margins, Operational Efficiency, and a shift to positive Adjusted EBITDA

Aptose Receives Second Advance under the Loan Agreement with Hanmi Pharmaceutical to Continue Development of Tuspetinib in Triplet Therapy for AML

Aptose has received an additional advance of US$2.0M from Hanmi Pharmaceutical Co. as part of a US$8.5M loan facility agreement.

Dr. Zachary Solomon Launches National Medical Tech Grant to Drive Healthcare Innovation Among U.S. Undergraduates

PHILADELPHIA, July 15, 2025 (GLOBE NEWSWIRE) -- Renowned cardiothoracic surgeon Dr. Zachary Solomon has officially announced the launch of the Dr. Zachary Solomon Medical Tech Grant, a prestigious academic initiative aimed at cultivating future leaders in medical technology and healthcare innovation. This national grant, open to undergraduate students across the United States, is designed to support aspiring professionals who are passionate about revolutionizing patient care through technology.

Comprehensive Healthcare Renames Yakima Walk-In Clinic to Wellness Now Clinic

Comprehensive Healthcare changes name of Yakima walk-in clinic to Wellness Now Clinic.

AZ Integrative & Functional Medicine Offering EXOMIND: Trailblazing Technology Using Brain Stimulation for Depression and Optimize Mental Health

EXOMIND launch event slated for July 25 SCOTTSDALE, Ariz., July 15, 2025 /PRNewswire/ -- For those seeking to lessen their anxiety, treat depression or enhance...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPatients

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers